Prospective Grant of Exclusive Patent License: Treatment and Prevention of Neuropathic Pain With P2Y14 Antagonists

Краткое содержание

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Saint Louis University, ("SLU"), a non-profit university located in Missouri, in its rights to the inventions and patents listed in the SUPPLEMENTARY INFORMATION section of this notice.